This study aims to evaluate the therapeutic impact of BYHWD on cognitive impairments in 3×Tg mice and to investigate its underlying mechanism through modulation of the gut microbiota–C/EBPβ/AEP signaling pathway. This evidence concerns the gene CEBPB and Cognitive impairment.